NGM Biopharmaceuticals News - NGM

Company Name	Stock Ticker Symbol	Market	Type
NGM Biopharmaceuticals Inc	NGM	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.54	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				1.54

more quote information »

Recent News

Date	Time	Source	Heading
4/05/2024	09:19	GLOBE	NGM Bio Announces Closing of Tender Offer
3/19/2024	17:30	GLOBE	NGM Bio to Present Two Posters Highlighting Clinical Data..
3/11/2024	16:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/2024	16:13	EDGAR2	Form 8-K - Current report
3/11/2024	16:05	GLOBE	NGM Bio Provides Recent Business Highlights and Reports..
3/08/2024	17:32	EDGAR2	Form SC 13E3 - Going private transaction by certain issuers
3/08/2024	17:21	EDGAR2	Form SC 14D9 - Solicitation, recommendation statements
2/26/2024	17:11	EDGAR2	Form SC14D9C - Written communication relating to third party..
2/26/2024	17:01	EDGAR2	Form 8-K - Current report
2/26/2024	09:03	GLOBE	NGM Bio Has Entered into a Definitive Agreement and Plan of..
2/20/2024	16:01	GLOBE	NGM Bio to Participate in the Cowen 44th Annual Health Care..
2/14/2024	18:12	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/22/2024	06:09	EDGAR2	Form 8-K - Current report
1/18/2024	18:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/18/2024	18:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/18/2024	18:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	16:47	GLOBE	NGM Bio to Participate in the B. Riley Securities 4th Annual..
1/09/2024	08:00	GLOBE	NGM Bio Announces New Clinical Data from Ongoing Trial of..
1/02/2024	07:30	EDGAR2	Form 8-K - Current report
12/04/2023	17:19	EDGAR2	Form 8-K - Current report
12/04/2023	16:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	09:45	GLOBE	NGM Bio Presents Positive Phase 2b Results from the ALPINE 4..
11/08/2023	18:13	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/08/2023	18:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	18:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/08/2023	18:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/07/2023	16:05	GLOBE	NGM Bio to Participate in Upcoming Investor Conferences
11/02/2023	16:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:06	EDGAR2	Form 8-K - Current report
11/02/2023	16:01	GLOBE	NGM Bio Reports Third Quarter 2023 Financial Results and..
10/17/2023	17:28	EDGAR2	Form 8-K - Current report
10/11/2023	16:05	GLOBE	NGM Bio Announces Oral Plenary Presentation of Data from..
9/27/2023	08:30	PRNUS	Alexandria Real Estate Equities, Inc.'s One-of-a-Kind,..
9/11/2023	16:01	EDGAR2	Form 8-K/A - Current report: [Amend]
8/11/2023	16:08	EDGAR2	Form 8-K - Current report
8/07/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
8/04/2023	17:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/2023	16:01	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
8/03/2023	16:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	16:07	EDGAR2	Form 8-K - Current report
8/03/2023	16:01	GLOBE	NGM Bio Reports Second Quarter 2023 Financial Results and..
5/25/2023	09:00	GLOBE	NGM Bio to Participate in Upcoming Investor Conferences
5/08/2023	16:05	GLOBE	NGM Bio Announces Presentation of Data from Phase 2..
5/04/2023	16:05	GLOBE	NGM Bio Reports First Quarter 2023 Financial Results and..